medcode,readcode,readterm,chemoradio 320,7M37100,Radiotherapy NEC,1 783,8BAD.00,CHEMOTHERAPY,1 1482,59...00,External radiotherapy,1 3622,5A11.00,Thyroid gland ablat - irradiat,1 5019,8BAD000,CANCER CHEMOTHERAPY,1 5404,7M0P.00,Introduction removable radioactive material into organ NOC,1 5527,ZV58000,[V]Radiotherapy session,1 8729,8J0..00,brachytherapy,1 9706,5154.00,Radiotherapy completed,1 10346,9N0D.00,Seen in radiotherapy clinic,1 10542,5A16.00,Radioactive drug therapy,1 10776,5A...11,Radiotherapy - internal,1 10932,8H67.00,Referred for radiotherapy,1 10950,ZL93100,Seen by radiotherapist,1 14887,8BA5.00,ORAL CHEMOTHERAPY,1 15362,7E0C000,Introduction of radioactive substance into uterine cavity,1 15386,7L16100,INTRAVENOUS CHEMOTHERAPY,1 16771,59...11,X-ray therapy -external,1 16935,515..00,Progress of radiotherapy,1 17048,863..12,radiation therapy,1 18675,8BAK.00,POST-OPERARTIVE CHEMOTHERAPY,1 18715,5AB..00,Stereotactic radiotherapy,1 18832,8BAa.00,DATE CHEMOTHERAPY COMPLETED,1 19467,8BAJ.00,PRE-OPERATIVE CHEMOTHERAPY,1 20282,7M0Py00,Introduction removable radioactive material to organ NOC OS,1 20336,7272200,Radiotherapy to lesion of retina,1 20381,ZV58100,[V]MAINTENANCE CHEMOTHERAPY,1 21318,8BA5.11,Oral cytotoxic drug therapy,1 22472,59Z..00,External radiotherapy NOS,1 22490,8BAL.00,COMBINED PRE-OPERATIVE CHEMOTHERAPY AND RADIOTHERAPY,1 23589,7M0Pz00,Introduction removable radioactive material to organ NOC NOS,1 25490,ZLD2400,Discharge by radiotherapist,1 26149,8CV1.00,CHEMOTHERAPY STARTED,1 28071,7L10200,CONTINUOUS INFUSION OF CHEMOTHERAPY,1 28427,7D03400,Implantation of radioactive substance into vulva,1 28712,8J01.00,Iodine seed radiotherapy,1 28809,8BAM.00,COMBINED POST-OPERATIVE CHEMOTHERAPY AND RADIOTHERAPY,1 29285,5149.00,Radiotherapy-tumour palliation,1 29301,514Z.00,Radiotherapy purpose - NOS,1 29679,5146.00,Radiotherapy - post-op.control,1 30264,7L19300,SUBCUTANEOUS CHEMOTHERAPY,1 30942,9N1yC00,Seen in radiotherapy clinic,1 31489,ZV58800,[V]CHEMOTHERAPY SESSION FOR NEOPLASM,1 31527,514..00,Purpose of radiotherapy,1 31804,TB12100,"Radiotherapy procedure with complication, without blame",1 32478,ZL13100,Under care of radiotherapist,1 35597,5147.00,Radiotherapy for analgesia,1 36225,5A4..11,Radium needles,1 36810,5AC..00,Strontium 89 therapy,1 37123,7L18200,INTRAMUSCULAR CHEMOTHERAPY,1 38466,5151.00,Radiotherapy started,1 38662,7M0P000,Introduction of radioactive caesium into organ NOC,1 38773,5A...00,Other nuclear therapy,1 39951,5A9..00,Selectron therapy,1 40070,7101100,Implantation of radioactive substance into pituitary gland,1 40310,D400312,Neutropenia due to irradiation,1 40490,7046200,INTRATHECAL CHEMOTHERAPY,1 41044,8J...00,Radiotherapy treatment groups,1 42351,591..00,X-ray beam therapy,1 42671,5A8..00,Other radiotherapy misc.,1 43261,5144.00,Radiotherapy - pre-op. control,1 44148,5914.11,Deep X-ray therapy,1 44831,5153.00,Radiotherapy stopped,1 45087,8H3L.00,Non-urgent radiotherapy admisn,1 45099,515Z.00,Radiotherapy progress NOS,1 46028,8BAY.00,DATE CHEMOTHERAPY STOPPED,1 46824,8H2G.00,Admit radiotherapy emergency,1 48991,5136.00,X-ray metastasis control,1 49760,U603318,[X] Adverse reaction to mitomycin,1 50731,7H2C000,Introduction of radioactive substance into peritoneal cavity,1 51563,TJ31B00,adverse reaction to fluorouracil,1 51781,ZVu3L00,[X]OTHER CHEMOTHERAPY,1 51787,5975.00,EXT.BEAM + CHEMOTHERAPY,1 51959,8BAI.00,AMBULATORY CHEMOTHERAPY,1 52368,TJ07100,adverse reaction to bleomycin,1 53180,5A46.00,Radioth.: temp. pelvic implant,1 54828,7D15400,Implantation of radioactive substance into vagina,1 54919,5A8Z.00,Other radiotherapy NOS,1 55261,5152.00,Radiotherapy changed,1 55828,5145.00,Radiotherapy -intra-op.control,1 55832,5143.00,Radioth. for lymphat.irradiat.,1 55836,5148.00,Radiotherapy for inflammation,1 57591,591Z.00,X-ray beam therapy NOS,1 58036,7220100,Radiotherapy to lacrimal gland,1 59684,7M0c.00,Radiotherapy procedures,1 59796,5914.00,Deep X-ray therapy 150-400 Kv,1 59890,5913.00,Half deep therapy 60-150 Kv,1 60076,5141.00,Radioth.for immunosuppression,1 60091,5912.00,Superfic.X-ray therapy 10-60Kv,1 60176,TJ31J00,adverse reaction to carboplatin,1 60399,TJ31400,adverse reaction to estramustine phosphate,1 60467,TJ31200,adverse reaction to chlorambucil,1 60674,7052200,Radiotherapy to lesion of peripheral nerve,1 61955,5AA..00,Iridium wire therapy,1 62202,8J00.00,High dose brachytherapy,1 62864,5A73.00,Radio-chemo.: oral route,1 62951,5A15.00,Bone tumour/metast.irradiat.,1 64100,TJ07300,adverse reaction to mitomycin,1 64143,597Z.00,Combined radiotherapy NOS,1 64801,5A3..00,Intern.radioth-permanent seeds,1 64997,7L1d.00,DELIVERY OF CHEMOTHERAPY FOR NEOPLASM,1 65739,5A53.00,Preload radioth.- nose,1 67248,5A12.00,Thyroid tumour/metast irradiat,1 68344,7244400,Radiotherapy to lesion of cornea,1 68423,7L1Z.00,Radiotherapy delivery,1 69165,594..00,Heavy particle therapy,1 69387,5974.00,EXT.BEAM-SURGERY+CHEMOTHERAPY,1 69877,5A3Z.00,Radioth.: permanent seeds NOS,1 69979,5AZ..00,Other nuclear therapy NOS,1 70128,D201311,Radiation aplastic anaemia,1 70246,5A1..00,Internal metabolic radiotherap,1 70290,5A7..00,RADIOMIMETIC CHEMOTHERAPY,1 70386,TA32.00,Overdose of radiation in therapy,1 70445,7M0cy00,Other specified radiotherapy procedures,1 70478,5A4..00,Radioth.: temporary implant,1 70549,5142.00,Radioth. for haemopo. irradiat,1 71008,7809400,Percutaneous radiofrequency ablation of lesion of liver,1 71098,592Z.00,High-energy beam therapy NOS,1 71598,5A45.00,Radioth.: temp. abdom. implant,1 71599,5A1Z.00,Internal metabolic radioth.NOS,1 71837,U603300,[X]OTHER ANTINEOPLAST DRUGS CAUS ADVERSE EFF IN THERAP USE,1 71926,5134.00,X-ray # reduction control,1 72850,5971.00,Extern.beam+intern.radiotherap,1 72978,597..00,Combined radiotherapy,1 73171,5A64.00,Afterload radioth.-fem.genital,1 73172,5A7Z.00,RADIO-CHEMOTHERAPY NOS,1 73173,5A13.00,Bone marrow suppres.-irradiat.,1 73300,5922.00,Betatron photon therapy,1 73462,5917.00,Intracavitary X-ray therapy,1 73692,5A4Z.00,Radioth.:temporary implant NOS,1 85234,7B3C900,seed implantation into prostate,1 85984,5941.00,Proton therapy,1 86329,7L1Z400,Oral delivery of radiotherapy for thyroid ablation,1 87860,7M0P300,Intro radioactive substance org interstit brachytherapy NOC,1 88367,7B0A800,Percutaneous radiofrequency ablation of lesion of kidney,1 88762,5135.00,Radiological tumour control,1 88889,7M0Q300,Radioactive seed implantation NOC,1 89452,7L1b.00,PROCUREMENT DRUGS FOR CHEMOTHERAPY FOR NEOPLASM IN BANDS 1-5,1 90743,7L1e.00,DELIVERY OF ORAL CHEMOTHERAPY FOR NEOPLASM,1 91102,7M0cz00,radiotherapy procedures nos,1 91433,7B3CB00,Radioactive seed implantation into prostate,1 91694,7L1Z300,Delivery of a fraction of external beam radiotherapy NEC,1 91778,7L1d000,Del comp chemo neo inc prolong infusion treat first attend,1 91891,7L1Zz00,Radiotherapy delivery NOS,1 91918,7272700,External beam radiotherapy to lesion of retina,1 92174,7454400,Percutaneous radiofrequency ablation of lesion of lung,1 92956,7L1Z011,Delivery of a fraction of total body irradiation,1 92999,5A27.00,Radioth.: infuse organ cavity,1 93607,5A81.00,Give radiosensitising drug,1 93669,7L1Y.00,Radiotherapy preparation,1 94305,596..00,Short dis.+contact radiotherap,1 94306,593..00,Fast-electron therapy,1 94431,7L1ez00,DELIVERY OF ORAL CHEMOTHERAPY FOR NEOPLASM NOS,1 94478,5A42.00,Radioth:temp.head/neck implant,1 94479,5973.00,Ext.beam-surg.+post-op.radioth,1 94617,5A62.00,Afterload radioth.- upper GIT,1 94760,U603316,[X] Adverse reaction to chlorambucil,1 94764,7L1Y000,Preparation for total body irradiation,1 95009,7L1Z100,Delivery of a fraction of intracavitary radiotherapy,1 95066,5961.00,Radium contact therapy,1 95098,5A33.00,Radioth.: seeds into cavity,1 95126,7L1Zy00,Other specified radiotherapy delivery,1 95424,7L1dz00,DELIVERY OF CHEMOTHERAPY FOR NEOPLASM NOS,1 95693,7L1Xy00,Other specified radiotherapy volume definition,1 95851,U603311,[X] ADVERSE REACTION TO ANTINEOPLASTIC ANTIBIOTICS,1 95890,5962.00,Beta source contact therapy,1 96310,7L1dy00,OTHER SPECIFIED DELIVERY OF CHEMOTHERAPY FOR NEOPLASM,1 96446,U613200,[X]Overdose of radiation given during therapy,1 96458,7L1Z000,Delivery of a fraction of total body irradiation (TBI),1 96467,5942.00,Deuteron therapy,1 96535,7B3BC00,Endoscopic radiofrequency ablation of lesion of prostate,1 97097,5131.00,Radiological pre-op. control,1 97106,5A28.00,Radioth.: infiltrate tissue,1 97154,5137.00,X-ray radiotherapy control,1 97253,7K1V700,Percutaneous radiofrequency ablation of lesion of bone,1 97412,7M0P400,Intro radioactive substance into organ for brachytherapy NOC,1 98358,7L1h000,Preparation for intensity modulated radiation therapy,1 98625,U603100,[X]ANTINEOPLAST ANTIMETABS CAUS ADVERSE EFF IN THERAP USE,1 98750,Z9KG500,Brachytherapy monitoring,1 98826,5A58.00,Preload radioth-female genital,1 98828,592..00,High-energy beam therapy,1 98829,5921.00,Linear-accelerator photon ther,1 98830,593Z.00,Fast-electron therapy NOS,1 98882,5A74.00,Radio-chemo.: I-V route,1 98902,7M0c500,Superficial or orthovoltage treatment for radiotherapy,1 98940,7L1i.00,Preparation for brachytherapy,1 99327,5963.00,Mould technique gamma/beta,1 99469,56B5.00,Image: field control:radiother,1 100382,5A21.00,Radioth.: infuse - skull/brain,1 100390,7M0P500,Intro non-remov radioact subst into organ for brachyther NOC,1 100396,7L1Z500,Delivery of a fraction of intraluminal brachytherapy,1 100724,5A2Z.00,Intern. unsealed radioth. NOS,1 100725,5A26.00,Radioth:infuse-urinary bladder,1 100758,5953.00,Comb.tele+int.dist.curietherap,1 100832,5133.00,Radiological post-op. control,1 100901,7M0c400,Megavoltage treatment for simple radiotherapy,1 100942,U60331B,[X] Adverse reaction to estramustine phosphate,1 101203,Z1Q1.11,Administering radionuclide,1 101391,7809300,Selective internal radiotherapy microspheres lesion of liver,1 101436,U603314,[X] Adverse reaction to bleomycin,1 101693,8CRC.00,Cancer chemotherapy management plan,1 101719,7B3E100,implantation of radioactive substance into prostate,1 102671,5A59.00,Preload radioth-urinary system,1 102672,5A14.00,Polycythaemia irradiation,1 102823,782M600,Percutaneous brachytherapy of lesion of bile duct,1 103302,U603200,[X]Antineoplast natural prod caus adverse eff in therap use,1 103372,5A2..00,Intern.radioth-unsealed source,1 103413,7L1i100,Preparation for intracavitary brachytherapy,1 103525,7L1Z200,Delivery of a fraction of interstitial radiotherapy,1 103600,U603118,[X] Adverse reaction to carboplatin,1 103872,7M0l.00,Support for preparation for radiotherapy,1 103957,7B3CA00,Transurethral radiofrequency needle ablation of prostate,1 104000,7L1h400,Prep for simple radioth with imaging and simple calculation,1 104099,7M0c300,Megavoltage treatment for complex radiotherapy,1 104142,8BAl.00,Neoadjuvant chemotherapy,1 105128,596Z.00,Short dist/contact radioth NOS,1 105129,5A57.00,Preload radioth.- resp.organs,1 105323,7M0c000,Delivery fraction complex radiotherapy megavoltage machine,1 105336,7L1d400,Electrochemotherapy,1 105610,7M0ly00,Other specified support for preparation for radiotherapy,1 106149,5933.00,Positron therapy,1 106334,5A22.00,Radioth.: infuse - head/neck,1 107069,7L1Yz00,Radiotherapy preparation NOS,1 107130,5A77.00,Radio-chem.: into cavity,1 107133,595..00,Gamma-ray+int.dist.curietherap,1 107175,5A51.00,Preload radioth.- orbit,1 107418,5A17.00,Combined internal radiotherapy,1 107525,7L1iz00,Preparation for brachytherapy NOS,1 107734,7L1d200,Deliver simple parenteral chemother neoplas first attendance,1 107914,U60331D,[X] Adverse reaction to antineoplastic antibiotics NOS,1 108138,7L2..00,Radiotherapy,1 108140,7L1hz00,Preparation for external beam radiotherapy NOS,1 108202,7M0c200,Delivery fraction radiotherapy superficial orthovoltage mach,1 108222,7M0p.00,brachytherapy,1 108240,7L20.00,radionuclide therapy,1 108561,7Q0J.00,Other chemotherapy drugs,1 109592,5932.00,Betatron electron therapy,1 110074,7M0p000,High dose rate brachytherapy,1 110894,SL07.00,Antineoplastic antibiotic poisoning,1 111213,7Q0J200,Other specified other chemotherapy drugs,1 111226,U603112,[X] Adverse reaction to fluorouracil,1 111244,7L1X000,Vol def radioth imag intensity-modul radia ther (IMRT) dosim,1 111583,D400300,Agranulocytosis due to irradiation,1 111949,7L1h100,Preparation for total body irradiation,1 112600,D201300,aplastic anaemia due to radiation,1 113181,TJ07.00,adverse reaction to antineoplastic antibiotics,1 113292,5A6Z.00,afterload cavity radioth. nos,1 113329,5918.00,combined x-ray therapy,1 113376,7L1d100,deliv complex parenteral chemotherapy neopl first attendance,1 113708,7L1d300,delivery subsequent element cycle chemotherapy for neoplasm,1 113797,7M0c100,delivery fraction simple radiotherapy megavoltage machine,1